Pharmacological Potential of NOX2 agonists in inflammatory conditions

Antioxidants and Redox Signaling

Volumn 23, Issue 5, 2015, Pages 446-459

  Hultqvist, Malin ^a   Olofsson, Peter ^a   Wallner, Fredrik K ^a   Holmdahl, Rikard ^b  

^a Redoxis AB   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATOR; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2 AGONIST; UNCLASSIFIED DRUG; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CHRONIC GRANULOMATOUS DISEASE; ENZYME ACTIVATION; HUMAN; IMMUNOPHARMACOLOGY; IMMUNOREGULATION; INFLAMMATORY DISEASE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; AGONISTS; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY;

ANIMALIA;

ANIMALS; AUTOIMMUNE DISEASES; ENZYME ACTIVATION; HUMANS; INFLAMMATION; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84904989604     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5788     Document Type: Review

References (124)

1. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G, Clarke F, Sitia R, and Rubartelli A. Antigenpresenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci USA 99: 1491-1496, 2002.
2. Babior BM. NADPH oxidase: An update. Blood 93: 1464-1476, 1999.
3. Bao S, Carr ED, Xu Y-H, and Hunt NH. Gp91(phox) contributes to the development of experimental inflammatory bowel disease. Immunol Cell Biol 89: 853-860, 2011.
4. Bedard K and Krause K-H. The NOX family of ROSgenerating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
5. Betten A, Bylund J, Christophe T, Cristophe T, Boulay F, Romero A, Hellstrand K, and Dahlgren C. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J Clin Invest 108: 1221-1228, 2001.
6. Bockaert J and Pin JP. Molecular tinkering of G proteincoupled receptors: An evolutionary success. EMBO J 18: 1723-1729, 1999.
7. Bokoch GM. Regulation of cell function by Rho family GTPases. Immunol Res 21: 139-148, 2000.
8. Borregaard N, Heiple JM, Simons ER, and Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: Translocation during activation. J Cell Biol 97: 52-61, 1983.
9. Bylund J, Brown KL, Movitz C, Dahlgren C, and Karlsson A. Intracellular generation of superoxide by the phagocyte NADPH oxidase: How, where, and what for? Free Radic Biol Med 49: 1834-1845, 2010.
10. Cale CM, Morton L, and Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: Incidence and autoimmune serology. Clin Exp Immunol 148: 79-84, 2007.
11. Castellani P, Angelini G, Delfino L, Matucci A, and Rubartelli A. The thiol redox state of lymphoid organs is modified by immunization: Role of different immune cell populations. Eur J Immunol 38: 2419-2425, 2008.
12. Chiarugi P. PTPs versus PTKs: The redox side of the coin. Free Radic Res 39: 353-364, 2005.
13. Cifuentes-Pagano E, Csányi G, and Pagano PJ. NADPH oxidase inhibitors: A decade of discovery from Nox2ds to HTS. Cell Mol Life Sci 69: 2315-2325, 2012.
14. Condliffe AM, Davidson K, Anderson KE, Ellson CD, Crabbe T, Okkenhaug K, Vanhaesebroeck B, Turner M, Webb L, Wymann MP, Hirsch E, Ruckle T, Camps M, Rommel C, Jackson SP, Chilvers ER, Stephens LR, and Hawkins PT. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 106: 1432-1440, 2005.
15. Conway KL, Goel G, Sokol H, Manocha M, Mizoguchi E, Terhorst C, Bhan AK, Gardet A, and Xavier RJ. p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation. J Immunol 189: 3631-3640, 2012.
16. Crotzer VL, Matute JD, Arias AA, Zhao H, Quilliam LA, Dinauer MC, and Blum JS. Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells. J Immunol 189: 3800-3804, 2012.
17. Dahlgren C and Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14, 1999.
18. Dahlgren C, Karlsson A, and Bylund J. Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol 412: 349-363, 2007.
19. de Loo van FAJ, Bennink MB, Arntz OJ, Smeets RL, Lubberts E, Joosten LAB, van Lent PLEM, Coenen-de Roo CJJ, Cuzzocrea S, Segal BH, Holland SM, and Den Berg Van WB. Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. Am J Pathol 163: 1525-1537, 2003.
20. De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, Balow JE, Barron KS, Turner ML, Gallin JI, and Malech HL. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 122: 1097-1103, 2008.
21. Deffert C, Carnesecchi S, Yuan H, Rougemont A-L, Kelkka T, Holmdahl R, Krause K-H, and Schäppi MG. Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells. J Pathol 228: 341-350, 2012.
22. Efimova O, Szankasi P, and Kelley TW. Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS One 6: E16013, 2011.
23. El-Benna J, Dang PM-C, Gougerot-Pocidalo M-A, Marie JC, and Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: Structure, phosphorylation and implication in diseases. Exp Mol Med 41: 217-225, 2009.
24. Ellson CD, Davidson K, Ferguson GJ, O'Connor R, Stephens LR, and Hawkins PT. Neutrophils from p40phox-/-mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J Exp Med 203: 1927-1937, 2006.
25. Ellson CD, Gobert-Gosse S, Anderson KE, Davidson K, Erdjument-Bromage H, Tempst P, Thuring JW, Cooper MA, Lim ZY, Holmes AB, Gaffney PR, Coadwell J, Chilvers ER, Hawkins PT, and Stephens LR. PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40(phox). Nat Cell Biol 3: 679-682, 2001.
26. Enyedi B, Zana M, Donkó A, and Geiszt M. Spatial and temporal analysis of NADPH oxidase-generated hydrogen peroxide signals by novel fluorescent reporter proteins. Antioxid Redox Signal 19: 523-534, 2013.
27. Follin P, Johansson A, and Dahlgren C. Intracellular production of reactive oxygen species in human neutrophils following activation by the soluble stimuli FMLP, dioctanoylglycerol and ionomycin. Cell Biochem Funct 9: 29-37, 1991.
28. Forsman H, Kalderén C, Nordin A, Nordling E, Jensen AJ, and Dahlgren C. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library. Biochem Pharmacol 81: 402-411, 2011.
29. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, and Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79: 247-256, 2006.
30. Geiszt M. NADPH oxidases: New kids on the block. Cardiovasc Res 71: 289-299, 2006.
31. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, and Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci USA 103: 12831-12836, 2006.
32. Gelderman KA, Hultqvist M, Olsson LM, Bauer K, Pizzolla A, Olofsson P, and Holmdahl R. Rheumatoid arthritis: The role of reactive oxygen species in disease development and therapeutic strategies. Antioxid Redox Signal 9: 1541-1567, 2007.
33. Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R, and Holmdahl R. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 117: 3020-3028, 2007.
34. Glogauer M, Marchal CC, Zhu F, Worku A, Clausen BE, Foerster I, Marks P, Downey GP, Dinauer M, and Kwiatkowski DJ. Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions. J Immunol 170: 5652-5657, 2003.
35. Goto T, Takahashi N, Kato S, Egawa K, Ebisu S, Moriyama T, Fushiki T, and Kawada T. Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytes. Biochem Biophys Res Commun 337: 440-445, 2005.
36. Greve B, Hoffmann P, Vonthein R, Kun J, Lell B, Mycko MP, Selmaj KW, Berger K, Weissert R, and Kremsner PG. NCF1 gene and pseudogene pattern: Association with parasitic infection and autoimmunity. Malar J 7: 251, 2008.
37. Gringhuis SI, Leow A, Papendrecht-Van Der Voort EA, Remans PH, Breedveld FC, and Verweij CL. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 164: 2170-2179, 2000.
38. Hagenow K, Gelderman KA, Hultqvist M, Merky P, Bäcklund J, Frey O, Kamradt T, and Holmdahl R. Ncf1-associated reduced oxidative burst promotes IL-33R + T cell-mediated adjuvant-free arthritis in mice. J Immunol 183: 874-881, 2009.
39. Hansson M, Romero A, Thorén F, Hermodsson S, and Hellstrand K. Activation of cytotoxic lymphocytes by interferon-alpha: Role of oxygen radical-producing mononuclear phagocytes. J Leukoc Biol 76: 1207-1213, 2004.
40. Hattori H, Subramanian KK, Sakai J, Jia Y, Li Y, Porter TF, Loison F, Sarraj B, Kasorn A, Jo H, Blanchard C, Zirkle D, McDonald D, Pai S-Y, Serhan CN, and Luo HR. Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. Proc Natl Acad Sci USA 107: 3546-3551, 2010.
41. Hayee B, Rahman FZ, Tempero J, McCartney S, Bloom SL, Segal AW, and Smith AM. The neutrophil respiratory burst and bacterial digestion in Crohn's disease. Dig Dis Sci 56: 1482-1488, 2011.
42. HehnerSP,Breitkreutz R, ShubinskyG,Unsoeld H, Schulze-Osthoff K, Schmitz ML, and Dröge W. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J Immunol 165: 4319-4328, 2000.
43. Holland SM. Chronic granulomatous disease. Clinic Rev Allerg Immunol 38: 3-10, 2010.
44. Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, and Holmdahl R. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 176: 1172-1179, 2006.
45. Holmdahl R, Sareila O, Pizzolla A, Winter S, Hagert C, Jaakkola N, Kelkka T, Olsson LM, Wing K, and Bäckdahl L. Hydrogen peroxide as an immunological transmitter regulating autoreactive T cells. Antioxid Redox Signal 18: 1463-1474, 2013.
46. Huang CK, Zhan L, Hannigan MO, Ai Y, and Leto TL. P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+ . J Leukoc Biol 67: 210-215, 2000.
47. Huang Z, Rose AH, and Hoffmann PR. The role of selenium in inflammation and immunity: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 16: 705-743, 2012.
48. Hultqvist M, Bäcklund J, Bauer K, Gelderman KA, and Holmdahl R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol 179: 1431-1437, 2007.
49. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, and Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med 3: E348, 2006.
50. Hultqvist M, Olofsson P, Holmberg J, Bäckström BT, Tordsson J, and Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 101: 12646-12651, 2004.
51. Hultqvist M, Olsson LM, Gelderman KA, and Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol 30: 201-208, 2009.
52. Hultqvist M, Sareila O, Vilhardt F, Norin U, Olsson LM, Olofsson P, Hellman U, and Holmdahl R. Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats. Antioxid Redox Signal 14: 2373-2383, 2011.
53. Jackson SH, Devadas S, Kwon J, Pinto LA, and Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Publishing Group 5: 818-827, 2004.
54. Jackson SH, Gallin JI, and Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751-758, 1995.
55. Jaquet V, Scapozza L, Clark RA, Krause K-H, and Lambeth JD. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11: 2535-2552, 2009.
56. Ju JY, Polhamus C, Marr KA, Holland SM, and Bennett JE. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/-knockout mice. Antimicrob Agents Chemother 46: 1240-1245, 2002.
57. Kandagaddala LD,KangM-J, HaqueMM, ImH-Y, Seo J-E, Chung BC, Jung BH, Patterson TA, and Kwon O-S. In vitro screening ofNADPHoxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice. J Neurol Sci 318: 36-44, 2012.
58. Karlsson A and Dahlgren C. Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 4: 49-60, 2002.
59. Kim J-A, Neupane GP, Lee ES, Jeong B-S, Park BC, and Thapa P. NADPH oxidase inhibitors: A patent review. Expert Opin Ther Pat 21: 1147-1158, 2011.
60. Kotsias F, Hoffmann E, Amigorena S, and Savina A. Reactive oxygen species production in the phagosome: Impact on antigen presentation in dendritic cells. Antioxid Redox Signal 18: 714-729, 2013.
61. Kraaij MD, der Kooij van SW, Reinders MEJ, Koekkoek K, Rabelink TJ, van Kooten C, and Gelderman KA. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol 49: 549-557, 2011.
62. Kraaij MD, Savage NDL, der Kooij van SW, Koekkoek K, Wang J, den Berg van JM, Ottenhoff THM, Kuijpers TW, Holmdahl R, van Kooten C, and Gelderman KA. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci USA 107: 17686-17691, 2010.
63. Kuiper JWP, Sun C, Magalha?es MAO, and Glogauer M. Rac regulates PtdInsP3 signaling and the chemotactic compass through a redox-mediated feedback loop. Blood 118: 6164-6171, 2011.
64. Kwon J, Shatynski KE, Chen H, Morand S, de Deken X, Miot F, Leto TL, and Williams MS. The nonphagocytic NADPH oxidase duox1 mediates a positive feedback loop during T cell receptor signaling. Sci Signaling 3: Ra59, 2010.
65. Lam GY, Huang J, and Brumell JH. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopathol 32: 415-430, 2010.
66. Lambeth JD, Kawahara T, and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43: 319-331, 2007.
67. Lambeth JD, Krause K-H, and Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 30: 339-363, 2008.
68. Lee BW and Yap HK. Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum 37: 773-776, 1994.
69. Lee K, Won HY, Bae MA, Hong JH, and Hwang ES. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b + and Th/Treg cells. Proc Natl Acad Sci USA 108: 9548-9553, 2011.
70. Leto TL, Morand S, Hurt D, and Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11: 2607-2619, 2009.
71. Lu S-P, Lin Feng M-H, Huang H-L, Huang Y-C, Tsou WI, and Lai M-Z. Reactive oxygen species promote raft formation in T lymphocytes. Free Radic Biol Med 42: 936-944, 2007.
72. Lundqvist H and Dahlgren C. Isoluminol-enhanced chemiluminescence: A sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med 20: 785-792, 1996.
73. Lundqvist H, Follin P, Khalfan L, and Dahlgren C. Phorbol myristate acetate-induced NADPH oxidase activity in human neutrophils: Only half the story has been told. J Leukoc Biol 59: 270-279, 1996.
74. Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O'Brien S, Hilligoss DM, Malech HL, Gallin JI, and Holland SM. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114: 462-468, 2004.
75. Mardiney M, Jackson SH, Spratt SK, Li F, Holland SM, and Malech HL. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 89: 2268-2275, 1997.
76. Matute JD, Arias AA, Wright NAM, Wrobel I, Waterhouse CCM, Li XJ, Marchal CC, Stull ND, Lewis DB, Steele M, Kellner JD, Yu W, Meroueh SO, Nauseef WM, and Dinauer MC. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 114: 3309-3315, 2009.
77. Michaelson D, Silletti J, Murphy G, D'Eustachio P, Rush M, and Philips MR. Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding. J Cell Biol 152: 111-126, 2001.
78. Mossberg N, Andersen O, Nilsson S, Dahlgren C,Hellstrand K, Lindh M, Svedhem A, Bergström T, and Movitz C. Oxygen radical production and severity of the Guillain-Barré syndrome. J Neuroimmunol 192: 186-191, 2007.
79. Mossberg N, Andersen O, Nordin M, Nilsson S, Svedhem A °, Bergström T, Hellstrand K, and Movitz C. Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome. J Inflamm (Lond) 7: 40, 2010.
80. Mossberg N, Movitz C, Hellstrand K, Bergström T, Nilsson S, and Andersen O. Oxygen radical production in leukocytes and disease severity in multiple sclerosis. J Neuroimmunol 213: 131-134, 2009.
81. Murphy MP, Holmgren A, Larsson N-G, Halliwell B, Chang CJ, Kalyanaraman B, Rhee SG, Thornalley PJ, Partridge L, Gems D, Nyström T, Belousov V, Schumacker PT, andWinterbourn CC. Unraveling the biological roles of reactive oxygen species. Cell Metab 13: 361-366, 2011.
82. Nakano Y, Longo-Guess CM, Bergstrom DE, Nauseef WM, Jones SM, and Banfi B. Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J Clin Invest 118: 1176-1185, 2008.
83. Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 122: 277-291, 2004.
84. Nauseef WM. How human neutrophils kill and degrade microbes: An integrated view. Immunol Rev 219: 88-102, 2007.
85. Ofek I, Goldhar J, Keisari Y, and Sharon N. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 49: 239-276, 1995.
86. Olofsson P, Lu S, Holmberg J, Song T, Wernhoff P, Pettersson U, and Holmdahl R. A comparative genetic analysis between collagen-induced arthritis and pristaneinduced arthritis. Arthritis Rheum 48: 2332-2342, 2003.
87. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerström B, and Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33: 25-32, 2003.
88. Olofsson P, Hultqvist, Hellgren L and Holmdah. R. Phytol-a chlorophyll component with anti-inflammatory and metabolic properties. In: Redox Active Secondary Metabolites: From Basic Chemistry to Widespread Applications in Medicine and Agriculture, edited by Jacob C, Burkholz T, Kirsch G, Slusarenko A, and Winyard, PG. Springer Science. [in press].
89. Olsson LM, Lindqvist A-K, Källberg H, Padyukov L, Burkhardt H, Alfredsson L, Klareskog L, and Holmdahl R. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther 9: R98, 2007.
90. Petry A,Weitnauer M, and Görlach A. Receptor activation of NADPH oxidases. Antioxid Redox Signal 13: 467-487, 2010.
91. Pizzolla A, Hultqvist M, Nilson B, Grimm MJ, Eneljung T, Jonsson I-M, Verdrengh M, Kelkka T, Gjertsson I, Segal BH, and Holmdahl R. Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. J Immunol 188: 5003-5011, 2012.
92. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, and Dinauer MC. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209, 1995.
93. Rahman FZ,Marks DJB, Hayee BH, Smith AM, Bloom SL, and Segal AW. Phagocyte dysfunction and inflammatory bowel disease. Inflamm Bowel Dis 14: 1443-1452, 2008.
94. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Publishing Group 3: 1129-1134, 2002.
95. Reyes BMR, Danese S, Sans M, Fiocchi C, and Levine AD. Redox equilibrium in mucosal T cells tunes the intestinal TCR signaling threshold. J Immunol 175: 2158-2166, 2005.
96. Rieber N, Hector A, Kuijpers T, Roos D, and Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol 2012: 252460, 2012.
97. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard E-J, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, and Brant SR. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39: 596-604, 2007.
98. Roberts RL, Hollis-Moffatt JE, Gearry RB, Kennedy MA, Barclay ML, and Merriman TR. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun 9: 561-565, 2008.
99. Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol 28 Suppl 1: S67-S72, 2008.
100. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, and Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426: 454-460, 2003.
101. Sakaguchi S, Sakaguchi N, Yoshitomi H, Hata H, Takahashi T, and Nomura T. Spontaneous development of autoimmune arthritis due to genetic anomaly of T cell signal transduction: Part 1. Semin Immunol 18: 199-206, 2006.
102. Salmeen A, Andersen JN, Myers MP, Meng T-C, Hinks JA, Tonks NK, and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
103. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, and Holmdahl R. NOX2 complex derived ROS as immune regulators. Antioxid Redox Signal 15: 2197-2208, 2011.
104. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Duménil A-M, Seabra MC, Raposo G, and Amigorena S. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218, 2006.
105. Schäppi M, Deffert C, Fiette L, Gavazzi G, Herrmann F, Belli D, and Krause K-H. Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice. J Pathol 214: 434-444, 2008.
106. Schepetkin IA, Kirpotina LN, Khlebnikov AI, and Quinn MT. High-throughput screening for small-molecule activators of neutrophils: Identification of novel N-formyl peptide receptor agonists. Mol Pharmacol 71: 1061-1074, 2007.
107. Schepetkin IA, Kirpotina LN, Tian J, Khlebnikov AI, Ye RD, and Quinn MT. Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production. Mol Pharmacol 74: 392-402, 2008.
108. Segal BH, Han W, Bushey JJ, Joo M, Bhatti Z, Feminella J, Dennis CG, Vethanayagam RR, Yull FE, Capitano M, Wallace PK, Minderman H, Christman JW, Sporn MB, Chan J, Vinh DC, Holland SM, Romani LR, Gaffen SL, Freeman ML, and Blackwell TS. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 5: E9631, 2010.
109. Segal BH, Veys P, Malech H, and Cowan MJ. Chronic granulomatous disease: Lessons from a rare disorder. Biol Blood Marrow Transplant 17: S123-S131, 2011.
110. Shao D, Segal AW, and Dekker LV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 550: 101-106, 2003.
111. Snelgrove RJ, Edwards L, Rae AJ, and Hussell T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 36: 1364-1373, 2006.
112. Thayer TC, Delano M, Liu C, Chen J, Padgett LE, Tse HM, Annamali M, Piganelli JD, Moldawer LL, and Mathews CE. Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes. Diabetes 60: 2144-2151, 2011.
113. Thorén F, Romero A, Lindh M, Dahlgren C, and Hellstrand K. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: Role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 76: 1180-1186, 2004.
114. Thorén FB, Betten A, Romero AI, and Hellstrand K. Cutting edge: Antioxidative properties of myeloid dendritic cells: Protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J Immunol 179: 21-25, 2007.
115. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11: 1289-1299, 2009.
116. Wheeler ML and Defranco AL. Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation. J Immunol 189: 4405-4416, 2012.
117. Whitmore LC, Hilkin BM, Goss KL, Wahle EM, Colaizy TT, Boggiatto PM, Varga SM, Miller FJ, and Moreland JG. NOX2 Protects against prolonged inflammation, lung injury, and mortality following systemic insults. J Innate Immun 5: 565-580, 2013.
118. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, and Dickler H. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169, 2000.
119. Yamauchi A, Kim C, Li S, Marchal CC, Towe J, Atkinson SJ, and Dinauer MC. Rac2-deficient murine macrophages have selective defects in superoxide production and phagocytosis of opsonized particles. J Immunol 173: 5971-5979, 2004.
120. Yang C-S, Kim J-J, Lee SJ, Hwang JH, Lee C-H, Lee M-S, and Jo E-K. TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1. J Immunol 190: 6368-6377, 2013.
121. Yu B, Chen Y, Wu Q, Li P, Shao Y, Zhang J, Zhong Q, Peng X, Yang H, Hu X, Chen B, Guan M, Wan J, and Zhang W. The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin Rheumatol 30: 521-527, 2011.
122. Zhang W-J, Wei H, and Frei B. Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo. Free Radic Biol Med 46: 791-798, 2009.
123. Zhu W, Meng L, Jiang C, He X, Hou W, Xu P, Du H, Holmdahl R, and Lu S. Arthritis is associated with T-cellinduced upregulation of Toll-like receptor 3 on synovial fibroblasts. Arthritis Res Ther 13: R103, 2011.
124. Zhu W, Meng L, Jiang C, Xu J, Wang B, Han Y, and Lu S. Overexpression of toll-like receptor 3 in spleen is associated with experimental arthritis in rats. Scand J Immunol 76: 263-270, 2012.